CF Benchmarks
CF benchmarks logo

Oct 03, 2025

CF Benchmarks Newsletter Issue 92


  • CME announces 24/7 crypto trading, as open interest surges
  • CF Benchmarks makes on-chain debut in Reserve Protocol’s LCAP DTF
  • REX-Osprey’s ’40 Act formula mints US ETH staking ETF, powered by CFB

Portfolio

There’s little doubt the pulse of the product issuance in the U.S. that quickened in the wake of the approval of Generic Listing Standards (GLS) last month, remains sharply in focus, with those developments most anticipated to follow, duly confirmed, or showing strong signs of materializing.

As expected, Grayscale’s CoinDesk Crypto 5 ETF (GDLC) was first out of the gate, stealing a march on a clutch of rival multi-asset filings, while simultaneously affirming their path to market.

GDLC’s holdings at launch, including ADA, XRP and SOL, as well as BTC and ETH, are instructive. There are no ’33 Act spot XRP, SOL, nor Cardano (ADA) ETPs as yet, though all of those assets are now available to trade on Designated Contract Markets (DCM).

This means GLDC constituents (assets and weights here, as reported by Blockworks) provide final validation of the GLS principle of implied, rather than express permission. That's a definitive green light for issuers teeing up their own multi-token offerings, including several proposing to lean on CF Benchmarks’ regulated index methodology for asset pricing.

Hashdex NCIQ expands

Among these, Hashdex looks set to be among the first firm with an existing multi-asset mandate, via the Hashdex Nasdaq Crypto Index US ETF (Ticker: NCIQ) listed in February, that will expand an existing portfolio with additional assets. (Till now, U.S. crypto portfolios could only invest in Bitcoin and Ether). In Hashdex's case, it will add XRP, SOL and XLM, to NCIQ's existing holdings in BTC and ETH. As per all Hashdex Nasdaq Crypto Index funds, listed in various domiciles, CF Benchmarks serves as their calculation agent for reference pricing.

Indexing in focus

Meanwhile, as suggested by the clip below, from a recent CF Benchmarks and Bitwise joint webinar, featuring Bitwise Head of Research, Ryan Rasmussen, early movers are likely to stress index construction as a differentiator.

0:00
/2:08

Click below to catch the full webinar.

With allocators looking poised to treat multi-asset funds as a core sleeve for crypto, it's also likely that bar has been raised in favor of proven, 'worry-free' index methodologies. Chiefly, those incorporating rules-based eligibility screens, liquidity filters and rebalancing, alongside replication practicality, and, of course, manipulation-resistance.

Whether packaged within our numerous portfolio indices, or as single assets for customized constitution, CF Benchmarks' regulated indices continue to fit the bill.


SOL tops solo chances

Among single-asset prospects, a raft of amended Solana filings points to SOL ETFs as a likely cohort for the next mass, or at least tightly grouped, approval.

The updated paperwork has been documented by Bloomberg's ETF sentinels in the usual way.

Multiple prospective issuers (e.g., Bitwise, 21Shares, Franklin) indicate intent to use the CME CF Solana-Dollar Reference Rate – New York Variant for pricing.


As is often the case, due to space and time constraints, we can only skim the top of a string of recent product-related highlights as the focus of the rest of this edition.


CME flags continuous crypto trading

Pending regulatory review, CME Group crypto futures and options will become available "24 hours a day, seven days a week, beginning in early 2026."

Although the group's announcement doesn't specify which assets will be included in round-the-clock trading, the suggestion is all CME crypto contracts, including the ones launched most recently, providing exposure to XRP and SOL, as well as longer established BTC and ETH contracts, will join the expanded trading window. (XRP and SOL options are set to launch on October 13th.)

All CME Group cryptocurrency derivatives and related products settle to regulated CF Benchmarks reference rates.

The release details "a two-hour weekly maintenance period" for weekends. Additionally, "All holiday or weekend trading from Friday evening through Sunday evening will have a trade date of the following business day, with clearing, settlement and regulatory reporting processed the following business day as well."

"Client demand for around-the-clock cryptocurrency trading has grown as market participants need to manage their risk every day of the week. Ensuring that our regulated cryptocurrency markets are always on will enable clients to trade with confidence at any time."

Tim McCourt, Global Head of Equities, FX and Alternative Products at CME Group, quoted in CME's press release.

The move is the latest example of CME's accelerated pace of crypto-related initiatives, which has emerged in step with a more accommodative regulatory atmosphere seen over the last several months.

Meanwhile, the decision also coincides with a recent run of record volume and open interest across CME's crypto product suite, as summarized below.

  • Total notional crypto open interest: $39 billion (September 18th)
  • August average daily open interest: 335,200 contracts, +95% year on year
  • August average daily volume (ADV): 411,000 contracts, +230% year on year
  • Large open interest holders (LOIH): >1,010, across crypto products in the week to September 25

The graphic below underscore that the move to 24/7 crypto product trading is timely, to say the least.

Source: CME Group, CF Benchmarks

In keeping with Ethereum's ongoing 'renaissance' over the last several months, it is clear from the next chart that it was CME Micro Ether futures trading that did much of the heavy lifting towards open interest milestones, year-on-year.

Key
Product code Contract
MBT Micro Bitcoin futures
MET Micro Ether futures
mSOL Micro SOL futures
sBTC Spot-Quoted Bitcoin futures
sETH Spot-Quoted Ether futures


At the very least, with non-stop CME crypto trading on the horizon amid increasingly deluxe liquidity conditions, the precision of already tight spreads around expiries should zero-in even further, when the transaction window widens across additional time zones.

That would indicate a virtuous cycle may be in the offing. Particularly if we assume increased systematic demand for benchmark-anchored hedges. All of which should reinforce the role of CME CF Reference Rates as the backstop of institutional settlement.


Reserve's LCAP is first regulated portfolio-based DTF

Reserve Protocol has deployed the CF Large Cap (Diversified Weight) – US – Settlement Price as the benchmark for a new Decentralized Token Folio (DTF).

The CF Large Cap Index DTF is the first use of a CF Benchmarks portfolio index in a DTF, bringing diversified exposure on-chain, with transparent, rules-based construction, and instant auditability. A DTF paired with a regulated portfolio benchmark brings all the replicability and governance benefits TradFi users of our indices are familiar with, into the world of DeFi.

It's an early step towards enabling regulated fiduciaries to square tokenized structures with institutional standards.

As tokenization rails improve, on-chain portfolios backed by regulated, manipulation-resistant indices should lower operational risk and make it easier for fiduciaries to justify incremental allocations.

Read our launch post below.

Reserve Protocol deploys Large Cap Index DTF (LCAP), first institutional-grade, on-chain crypto portfolio
CF Benchmarks congratulates Reserve Protocol on the successful deployment of the Large Cap Index Decentralized Token Folio (LCAP) — the first ever fully collateralized, on-chain, multi-asset index tracker.

REX-Osprey's latest first: ETH staking

REX-Osprey has listed its ETH + Staking ETF (ESK)—the first U.S. ETF to offer access to direct ETH staking rewards.

ESK is REX-Osprey's fourth crypto ETF since July to use a CF Benchmarks Reference Rate. For ESK's ETH reference price (excluding staking rewards) the index is our CME CF Ether-Dollar Reference Rate – New York Variant.

Each crypto ETF in the group's recent run of launches is registered under the ’40 Act, a framework that can accelerate time-to-market, albeit with implied structural limits, especially following the approval of GLS.

For now though, REX-Osprey's creditable introduction of ESK brings staking economics into a listed wrapper for the first time, while retaining ETHUSD_NY for representative, replicable tracking.

It's worth noting these ETF debuts have this week resulted in the group's assets under management surpassing the $500 million milestone. With the partnership in place for less than a year, it's a pace of asset gathering that speaks for itself.

Read our launch post below.

REX-Osprey lists first US ETH ETF with direct staking rewards
CF Benchmarks is delighted that REX-Osprey has once again opted to select a regulated CF Benchmarks index as the reference price for another of its crypto ETFs, this time our CME CF Ether-Dollar Reference Rate – New York Variant (ETHUSD_NY).


The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.


Note: Some of the underlying instruments cited within this material may be restricted to certain customer categories in certain jurisdictions.


Factor Friday - April 10, 2026

The market posted its strongest week of 2026 at +7.1%. However, factor breadth was notably thin. Size was the only non-market factor to finish positive at +1.3%, while growth and value lagged, suggesting the rally was driven by directional flows rather than fundamentals.

Mark Pilipczuk
Mark Pilipczuk

Mark Pilipczuk

9 mins read
CFB Talks Digital Assets Episode 56: Live X Space - Bitcoin In Crisis

Head of Research Gabe Selby, CFA is joined by Kraken's Chief Economist Thomas Perfumo, CFA, CF Benchmarks Research Analyst, Mark Pilipczuk, and Senior Product Manager, Cristian Isac.

Ken Odeluga
Ken Odeluga

Ken Odeluga

1 mins read
Announcement of Consultation on Changes to the CME CF Bitcoin Volatility Index - Settlement Methodology

The Administrator is launching a consultation on proposed changes to the CME CF Bitcoin Volatility Index - Settlement (BVXS) Methodology.

CF Benchmarks
CF Benchmarks

CF Benchmarks

1 mins read

Footer

Subscribe to our newsletter

The latest news, articles, and resources, sent to your inbox weekly.

By submitting this form, you agree to our Terms of Service and Privacy Policy.

Already subscribed? Manage your preferences

© 2026 CF Benchmarks Ltd. All rights reserved.

CF Benchmarks Ltd (“CF Benchmarks”), a company registered in England and Wales with company number 11654816 and authorised and regulated by the Financial Conduct Authority. Information about us can be found on the Financial Services Register (register number 847100).

Registered Office: 6th Floor One London Wall, London, United Kingdom, EC2Y 5EB.

You agree not to, and have no rights to, use the CF Benchmarks Data to create, calculate, issue, settle, maintain, support or develop any financial instruments (including but, without limitation exchange traded products, certificates, warrants, contracts for difference, swaps, binary options, structured products), indices, products, services (including but without limitation, portfolio management services, pre- and post-trade risk management services, or valuation services) or any other derivative works without the express written consent of CF Benchmarrks.

You agree not to analyze, reverse-engineer or disassemble any CF Benchmarks data and not to insert any code or product to manipulate the Website content in any way that affects any user’s experience. Unless CF Benchmarks gives you prior written permission, use of any Web browsers (other than generally available third-party browsers), engines, scripts, software, spiders, robots, avatars, agents, tools or other devices or mechanisms (such as crawlers, browser plug-ins and add-ons, or other technology) to navigate, access, copy in bulk, retrieve, harvest, index, search or analyse any portion of the Website is strictly prohibited.

No part of this information may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of CF Benchmarks Ltd. Use and distribution of the CF Benchmarks data requires a license from CF Benchmarks or its authorized licensing agents.

All information is provided for information purposes only. All information and data contained on this website is obtained by CF Benchmarks, from sources believed by it to be accurate and reliable. Such information and data is provided "as is" without warranty of any kind.

CF Benchmarks, nor its directors, officers, employees, partners or licensors make any claim, prediction, warranty or representation whatsoever, expressly or implied, either as to the accuracy, timeliness, completeness or merchantability of any information or of results to be obtained from the use of the CF Benchmarks indices or the fitness or suitability of the same indices for any particular purpose to which they might be put. Any representation of historical data accessible through CF Benchmarks indices is provided for information purposes only and is not a reliable indicator of future performance.

No responsibility or liability can be accepted by CF Benchmarks nor their respective directors, officers, employees, partners or licensors for any loss or damage in whole or in part caused by, resulting from, or relating to any error (negligent or otherwise) or other circumstance involved in procuring, collecting, compiling, interpreting, analysing, editing, transcribing, transmitting, communicating or delivering any such information or data or from use of this website or links to this website.

CF Benchmarks and its respective directors, officers, employees, partners or licensors do not provide investment advice and nothing accessible through CF Benchmarks, should be taken as constituting financial or investment advice or a financial promotion. Charts and graphs are provided for illustrative purposes only. Index returns shown may not represent the results of the actual trading of any assets.

CF Benchmarks is a member of the Crypto Facilities group of companies which is in turn a member of the Payward, Inc. group of companies.
  • Payward, Inc. is the owner and operator of the Kraken Exchange, a venue that facilitates the trading of cryptocurrencies. The Kraken Exchange is a source of input data for certain CF Benchmarks indices.
  • Payward, Inc. is the owner and operator of the Staked, a venue that operates the block production nodes for decentralized PoS protocols on behalf of institutional investors. Staked.us is a source of input data for certain CF Benchmarks indices.

Please refer to the individual product family documentation for more information about applicable input data sources.

By clicking Accept, you consent to CF Benchmarks's use of cookies.

Visit Cookie Settings to learn how CF Benchmarks uses cookies and to adjust your preferences.